HEALTH● LOWSep 28 · Sep 28, 2026, 8:57 PM
Teva wins biosimilar approval of Amgen's Xgeva
Seeking Alpha Tech · global
Teva has received approval for a biosimilar version of Amgen's drug, Xgeva. This development introduces competition for the original drug and expands treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoThe health of Leo XIV: the Pope advances in his recovery, but uncertainty remains about his visit to South AmericaClarínHEALTH2h agoHealthcare workers protest in virtually every state over pay, shortages and staffingMexico News DailyHEALTH3h agoKFF: Individual health insurance enrollment fell 18 percent in JuneThe HillHEALTH3h agoPaxton suing Gerber and Nestlé over alleged arsenic and lead in baby foodThe Hill